Downstream targets of WRKY33

Klaus Petersen1, Berthe Katrine Fiil, John Mundy

  • 1Department of Biology; University of Copenhagen; Copenhagen Denmark.

Insights

Mitogen-activated protein kinase (MAPK) cascades regulate plant innate immunity. WRKY33 transcription factor targets defense genes, including those for camalexin synthesis, crucial for pathogen resistance.

Area of Science:

  • Plant biology
  • Molecular biology
  • Biochemistry

Background:

  • Plant innate immunity relies on signaling pathways, including mitogen-activated protein kinase (MAPK) cascades.
  • MPK4, MKS1, and WRKY33 are key components in these immune signaling pathways.

Purpose of the Study:

  • To investigate the role of WRKY33 in plant defense responses against pathogens.
  • To identify and characterize WRKY33 target genes involved in immunity.

Main Methods:

  • In vivo protein interaction assays (MPK4, MKS1, WRKY33).
  • Transcriptome analysis of wrky33 loss-of-function mutants.
  • Chromatin immunoprecipitation (ChIP) to confirm gene binding.
  • Analysis of defense-related gene expression.

Main Results:

  • WRKY33 interacts with MPK4 and MKS1, and is released upon pathogen infection.
  • WRKY33 directly regulates defense genes like PAD3 and CYP71A13, essential for camalexin production.
  • WRKY33 also targets NUDT6 and ROF2, implicating them in pathogen defense.

Conclusions:

  • WRKY33 is a crucial transcription factor in plant immunity, mediating defense gene activation.
  • The WRKY33-MPK4 pathway is vital for mounting effective antimicrobial responses through phytoalexin synthesis.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...